Zhongshan Laibo Ruichen Biomedicine Co., Ltd.

First Subject Enrolled in Phase II Clinical Trial of World's First Osteonecrosis Drug RAB001!

Rabpharma Wins Silver Award at Greater Bay Area Postdoctoral Innovation Competition!

Groundbreaking: Rabpharma Officially Launches Phase II Clinical Trial of RAB001 at Shanghai Sixth People's Hospital!

Rabpharma Wins "Outstanding Enterprise Award" at National Finals of China Innovation & Entrepreneurship Competition!

RAB001 Receives Phase II Clinical Trial Approval!